Innoviva
(NASDAQ:INVA)
$13.18
At close: Dec 1(Delayed 15-Minutes)
Get Real Time Here
$13.18
PreMarket: 4:01PM EDT
Day Range- - -52 Wk Range11.57 - 20.71Open / Close- / -Float / Outstanding60.4M / 69.8M
Vol / Avg.- / 601.1KMkt Cap919.7MP/E3.9850d Avg. Price12.95
Div / Yield-Payout Ratio-Total Float60.4MEPS3.81

Innoviva Stock (NASDAQ:INVA), Quotes and News Summary

Innoviva Stock (NASDAQ: INVA) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range11.57 - 20.71Open / Close- / -Float / Outstanding60.4M / 69.8M
Vol / Avg.- / 601.1KMkt Cap919.7MP/E3.9850d Avg. Price12.95
Div / Yield-Payout Ratio-Total Float60.4MEPS3.81
Business Wire - Jul 11, 2022, 9:17AM
Business Wire - Jul 11, 2022, 7:30AM
Globe Newswire - May 23, 2022, 8:30AM
Business Wire - May 23, 2022, 8:30AM
Business Wire - Apr 27, 2022, 5:11PM
InvestorPlace - Oct 31, 2022, 7:20PM
InvestorsObserver - Oct 13, 2022, 12:19PM
InvestorsObserver - Sep 27, 2022, 3:44PM
Seeking Alpha - Sep 19, 2022, 3:40PM
InvestorPlace - Sep 2, 2022, 6:00AM
Seeking Alpha - Jun 7, 2022, 2:58PM
Seeking Alpha - Jun 7, 2022, 2:58PM
Seeking Alpha - Feb 21, 2022, 2:05PM
Sector: Health Care.Industry: Pharmaceuticals
Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others. The firm collaborates with and receives funding from GlaxoSmithKline.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-08
REV
Q3 2022Est.ActualSurprise
EPS2.2402.800 0.5600
REV200.480M67.257M-133.223M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Innoviva (INVA) stock?

A

You can purchase shares of Innoviva (NASDAQ: INVA) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Innoviva (INVA) stock?

A

The latest price target for Innoviva (NASDAQ: INVA) was reported by Morgan Stanley on Thursday, October 13, 2022. The analyst firm set a price target for 14.00 expecting INVA to rise to within 12 months (a possible 6.22% upside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Innoviva (INVA)?

A

The stock price for Innoviva (NASDAQ: INVA) is $13.18 last updated December 1, 2022, 9:00 PM UTC.

Q

Does Innoviva (INVA) pay a dividend?

A

There are no upcoming dividends for Innoviva.

Q

When is Innoviva (NASDAQ:INVA) reporting earnings?

A

Innoviva’s Q4 earnings are confirmed for Wednesday, February 8, 2023.

Q

Is Innoviva (INVA) going to split?

A

There is no upcoming split for Innoviva.

Q

What sector and industry does Innoviva (INVA) operate in?

A

Innoviva is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.